{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:51:25Z","timestamp":1785549085609,"version":"3.56.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.vaccine.2022.05.020","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T22:39:23Z","timestamp":1658356763000},"page":"A128-A135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"S1","title":["Exploring public perceptions of vaccine-derived poliovirus and a novel oral polio vaccine in the Democratic Republic of the Congo, Kenya, and Nigeria"],"prefix":"10.1016","volume":"41","author":[{"given":"Lara","family":"Lorenzetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rustam","family":"Haydarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Namey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lawton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayon","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhamad","family":"Ridwan Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Monj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surangani","family":"Abeyesekera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Amina Kabwau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.05.020_b0005","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-020-02501-3","article-title":"Africa declared free from wild polio - but vaccine-derived strains remain","author":"Guglielmi","year":"2020","journal-title":"Nature"},{"issue":"6585","key":"10.1016\/j.vaccine.2022.05.020_b0010","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.adb1920","article-title":"Africa battles out-of-control polio outbreaks","volume":"375","author":"Roberts","year":"2022","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.vaccine.2022.05.020_b0015","doi-asserted-by":"crossref","first-page":"e1345","DOI":"10.1016\/S2214-109X(20)30382-X","article-title":"Certifying the interruption of wild poliovirus transmission in the WHO African region on the turbulent journey to a polio-free world","volume":"8","author":"Fomban Leke","year":"2020","journal-title":"The Lancet Global Health"},{"key":"10.1016\/j.vaccine.2022.05.020_b0020","unstructured":"Global Polio Eradication Initiative. This Week: Wild poliovirus type 1 and circulating vaccine-derived poliovirus cases. GPEI; 2020."},{"key":"10.1016\/j.vaccine.2022.05.020_b0025","unstructured":"Global Polio Eradication Initiative. This Week: Wild poliovirus type 1 and circulating vaccine-derived poliovirus cases. GPEI; 2022."},{"key":"10.1016\/j.vaccine.2022.05.020_b0030","article-title":"The impact of disruptions caused by the COVID-19 pandemic on global polio eradication","author":"Kalkowska","year":"2021","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2022.05.020_b0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1473-3099(21)00458-8","article-title":"Polio eradication: what kind of world do we want?","volume":"22","author":"Thompson","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2022.05.020_b0040","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/14760584.2018.1506333","article-title":"Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccine","volume":"17","author":"Duintjer Tebbens","year":"2018","journal-title":"Exp Rev Vacc"},{"key":"10.1016\/j.vaccine.2022.05.020_b0045","unstructured":"Global Polio Partners Group. Updates on type 2 OPV containing vaccines & IPV. UNICEF; 2019."},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.020_b0050","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-022-00437-5","article-title":"Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in children","volume":"7","author":"Wahid","year":"2022","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2022.05.020_b0055","series-title":"First ever vaccine listed under WHO emergency use","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.vaccine.2022.05.020_b0060","unstructured":"Global Polio Eradication Initiative. Novel Oral Polio Vaccine type 2 (nOPV2) granted EUL recommendation. In: GPEI, editor. WHO has issued an Emergency Use Listing recommendation for the type 2 novel oral polio vaccine (nOPV2). Geneva, Switzerland; 2020."},{"issue":"10","key":"10.1016\/j.vaccine.2022.05.020_b0065","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1080\/21645515.2018.1460987","article-title":"Vaccine hesitancy \u2013 a potential threat to the achievements of vaccination programmes in Africa","volume":"14","author":"Cooper","year":"2018","journal-title":"Human Vacc Immunotherapeut"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.020_b0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1525822X05279903","article-title":"How Many Interviews Are Enough?","volume":"18","author":"Guest","year":"2006","journal-title":"Field Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.020_b0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1525822X16639015","article-title":"How Many Focus Groups Are Enough? Building an Evidence Base for Nonprobability Sample Sizes","volume":"29","author":"Guest","year":"2017","journal-title":"Field Methods"},{"key":"10.1016\/j.vaccine.2022.05.020_b0080","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1471-2288-13-117","article-title":"Using the framework method for the analysis of qualitative data in multi-disciplinary health research","volume":"13","author":"Gale","year":"2013","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.vaccine.2022.05.020_b0085","unstructured":"FHI 360. Perceptions about Change in Oral Polio Vaccine (OPV) Use and Introduction of Novel OPV. Durham, NC, USA: FHI 360; 2020."},{"key":"10.1016\/j.vaccine.2022.05.020_b0090","doi-asserted-by":"crossref","unstructured":"Aborode AT, Fajemisin EA, Ekwebelem OC, Tsagkaris C, Taiwo EA, Uwishema O, et al. Vaccine hesitancy in Africa: causes and strategies to the rescue. Therapeutic Adv Vacc Immunother 2021;9:25151355211047514.","DOI":"10.1177\/25151355211047514"},{"issue":"10268","key":"10.1016\/j.vaccine.2022.05.020_b0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(20)32540-X","article-title":"Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials","volume":"397","author":"S\u00e1ez-Llorens","year":"2021","journal-title":"The Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2022.05.020_b0100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/risa.13622","article-title":"Updated Characterization of Outbreak Response Strategies for 2019\u20132029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain","volume":"41","author":"Kalkowska","year":"2021","journal-title":"Risk Anal: An Off Publicat Soc Risk Anal"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22005916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22005916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:24:05Z","timestamp":1759404245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22005916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":20,"alternative-id":["S0264410X22005916"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.05.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring public perceptions of vaccine-derived poliovirus and a novel oral polio vaccine in the Democratic Republic of the Congo, Kenya, and Nigeria","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}